Table 2 Descriptive analysis of biochemical and autoantibody parameters in successive time stations in BN/AMA+ individuals and PBC patients

69.2 (27–158)

35.3 (3–265)

7.9 (6–9.9)

2.0 (0.1–6.0)

61 (16–118)

320 (40–20,480)

71.3 (28–105)

45.2 (8–191)

8.4 (6.4–10.5)

1.9 (0.3–6.4)

54 (Ø–105)

640 (Ø–10,240)

63.4 (30–127)

33.2 (6–148)

8.8 (7.3–10.5)

2.4 (0.2–5.9)

55 (Ø–101)

160 (Ø–10,240)

62.2 (31–131)

31.2 (4–179)

8.8 (7.2–10.7)

2.4 (0.2–5.9)

70 (33–99)

640 (Ø–20,480)

63.0 (38–79)

25.2 (7–99)

9.2 (7.4–10.8)

2.9 (0.2–7.0)

62 (Ø–101)

480 (Ø–10,240)

72.0 (42–198)

31.9 (10–111)

8.7 (5.8–10.2)

2.4 (0.2–7.4)

63 (Ø–97)

320 (Ø–10,240)

79.0 (42–126)

39.8 (7–82)

9.3 (8.5–11.2)

3.9 (0.2–7.7)

88 (5–121)

640 (160–20480)

52.8 (37–67)

82.2 (12–308)

9.2 (9–9.5)

2.5 (0.3–4.9)

64 (Ø–93)

160 (Ø–2560)

200.4 (52–776)

226.8 (10–1221)

8.6 (5.8–13.5)

2.9 (0.2–7.2)

68 (26–105)

1280 (40–20,480)

138.5 (77–360)

145.6 (15–524)

9.1 (7–10.6)

3.4 (0.4–7.4)

71 (Ø–97)

1280 (Ø–5120)

86.7 (35–128)

95.6 (19–341)

9.1 (6.9–11.4)

3.4 (0.4–6.7)

69 (Ø–96)

480 (Ø–5120)

138.7 (46–490)

105.7 (10–307)

9 (4.7–12.5)

3.6 (0.4–7.8)

77 (Ø–112)

1280 (80–20,480)

130.6 (55–259)

144.1 (13–473)

9.7 (7.8–13.4)

3.4 (0.3–6.4)

77 (Ø–104)

1280 (Ø–10,240)

311.6 (66–518)

387.8 (10–1545)

10.6 (9.1–12.1)

5.1 (1.7–7.4)

81 (3–105)

1280 (40–10,240)

167.3 (65–359)

138.6 (13–579)

9.7 (8.4–12)

4.3 (0.3–6.7)

90 (59–107)

1280 (320–10,240)

190.0 (110–527)

258.4 (21–1448)

11.2 (10–12.1)

5.5 (2.6–7.2)

91 (68–108)

1280 (320–10,240)